About Us

MyndTec is a neurotechnology company dedicated to improving the lives of individuals affected by central nervous system injuries, including stroke and spinal cord injury (SCI), neurological disorders, and chronic pain. With over a decade of experience treating neurological patients, we have built a strong foundation of clinical insights, patient data, and a proven track record of navigating FDA and Health Canada regulatory requirements.

What We Do

We develop AI-powered and neuromodulation solutions that transform how neurological conditions are treated and managed. MyndTec brings over a decade of experience treating neurological patients, generating invaluable patient data and clinical insights that uniquely position us to understand what works — and what doesn’t — in real-world neurological care.

Our commercial product, MyndMove™, is a non-invasive Functional Electrical Stimulation (FES) therapy authorized in both the U.S. and Canada that helps patients with paralysis from stroke or SCI regain voluntary arm and hand function by stimulating new neural pathways through neuroplasticity. Building on this clinical foundation, our next-generation platform MyndLink™ is an AI-powered therapy assistant that delivers real-time, data-driven recommendations and predictive analytics — helping healthcare providers optimize treatment protocols, automate clinical documentation, and improve patient outcomes across stroke rehabilitation, spinal cord injury recovery, and chronic pain management.

By combining proven neuromodulation therapy with AI-driven intelligence, MyndTec delivers AI-enhanced treatments that improve patient outcomes and reduce healthcare costs — creating measurable value for patients, providers, and payers alike.

Mission

To revolutionize neurological care by combining proven neuromodulation therapies with AI-driven intelligence — restoring patient independence, improving neurological function, and delivering lasting, measurable health outcomes.

Vision

To lead the future of neurological care through precision-based, data-driven treatments that bring transformative therapies to patients, providers, and healthcare systems worldwide.